Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-25-004893
Filing Date
2025-06-17
Accepted
2025-06-17 16:25:41
Documents
2
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 3893
2 SECTION 16 POA - COLE coleex24.txt EX-24 3531
  Complete submission text file 0001562180-25-004893.txt   8902
Mailing Address AVEO PHARMACEUTICALS, INC. 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Cole Douglas G. (Reporting) CIK: 0001486373 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39634 | Film No.: 251053646

Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Issuer) CIK: 0001822462 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)